GTEX-14LZ3
|
61-70
|
Female
|
GTEX-14LZ3-0826 |
Liver
|
PAXgene |
2
|
2 pieces; mild congestion, includes focus of larger vessels/duct/nerve
|
Acceptable
|
 |
GTEX-14PHW
|
61-70
|
Female
|
GTEX-14PHW-1726 |
Liver
|
PAXgene |
2
|
2 pieces, marked subacute central cardiac congestion
|
Acceptable
|
 |
GTEX-14PHX
|
51-60
|
Male
|
GTEX-14PHX-0526 |
Liver
|
PAXgene |
1
|
2 pieces
|
Acceptable
|
 |
GTEX-14PII
|
61-70
|
Male
|
GTEX-14PII-1926 |
Liver
|
PAXgene |
1
|
2 pieces, marked mascrovesicular steatosis in ~50% parenchyma, centrilobular distribution; moderate passive congestion
|
Acceptable
|
 |
GTEX-14PJ2
|
51-60
|
Male
|
GTEX-14PJ2-1326 |
Liver
|
PAXgene |
1
|
2 pieces; periportal and peribiliary chronic inflammation and fibrosis encroaching on liver parenchyma
|
Acceptable
|
 |
GTEX-14PJM
|
51-60
|
Female
|
GTEX-14PJM-1926 |
Liver
|
PAXgene |
1
|
2 pieces; slight congestion
|
Acceptable
|
 |
GTEX-14PJO
|
61-70
|
Male
|
GTEX-14PJO-1726 |
Liver
|
PAXgene |
1
|
2 pieces; severe central congestion & degeneration
|
Acceptable
|
 |
GTEX-14PN4
|
51-60
|
Male
|
GTEX-14PN4-1126 |
Liver
|
PAXgene |
1
|
2 pieces; cirrhosis
|
Acceptable
|
 |
GTEX-14PQA
|
51-60
|
Female
|
GTEX-14PQA-1326 |
Liver
|
PAXgene |
2
|
2 pieces; congestion and mild fatty change
|
Acceptable
|
 |
GTEX-14XAO
|
61-70
|
Female
|
GTEX-14XAO-0226 |
Liver
|
PAXgene |
1
|
2 pieces, no significant steatosis or hepatitis
|
Acceptable
|
 |
GTEX-15CHQ
|
61-70
|
Male
|
GTEX-15CHQ-0926 |
Liver
|
PAXgene |
2
|
2 pieces; moderate central congestion, hemorrhage and cellular degeneration consistent with heart failure
|
Acceptable
|
 |
GTEX-15CHS
|
51-60
|
Male
|
GTEX-15CHS-1426 |
Liver
|
PAXgene |
1
|
2 pieces, ~10% macrovesicular steatosis
|
Acceptable
|
 |
GTEX-15D1Q
|
41-50
|
Male
|
GTEX-15D1Q-1426 |
Liver
|
PAXgene |
1
|
2 pieces marked macrovesicular steatosis involves >90% of parenchyma
|
Acceptable
|
 |
GTEX-15D79
|
51-60
|
Male
|
GTEX-15D79-2326 |
Liver
|
PAXgene |
1
|
2 pieces; moderate (40%) macrovesicular steatosis; bridging fibrosis
|
Acceptable
|
 |
GTEX-15DCD
|
61-70
|
Female
|
GTEX-15DCD-0826 |
Liver
|
PAXgene |
1
|
2 pieces; grade 1 to 2 autolysis; passive congestion
|
Acceptable
|
 |
GTEX-15DCZ
|
21-40
|
Female
|
GTEX-15DCZ-1526 |
Liver
|
PAXgene |
1
|
2 pieces, moderate congestions; macrovesicular steatosis in ~20% of parenchyma
|
Acceptable
|
 |
GTEX-15DDE
|
51-60
|
Female
|
GTEX-15DDE-1726 |
Liver
|
PAXgene |
1
|
2 pieces, mild - moderate congestion
|
Acceptable
|
 |
GTEX-15DYW
|
61-70
|
Female
|
GTEX-15DYW-1326 |
Liver
|
PAXgene |
2
|
2 pieces; moderate congestion; severe central atrophy
|
Acceptable
|
 |
GTEX-15EO6
|
51-60
|
Male
|
GTEX-15EO6-1626 |
Liver
|
PAXgene |
2
|
2 pieces, advanced cirrhosis/chronic hepatitis
|
Acceptable
|
 |
GTEX-15EOM
|
21-40
|
Female
|
GTEX-15EOM-1126 |
Liver
|
PAXgene |
1
|
2 pieces; includes capsule (target is 1cm below capsule), bridging fibrosis with expanded portal tracks and lymphocytic infiltrate, history of sclerosis cholangitis, congestion
|
Acceptable
|
 |
GTEX-15ER7
|
21-40
|
Female
|
GTEX-15ER7-1826 |
Liver
|
PAXgene |
1
|
2 pieces; congestion, mild fatty change
|
Acceptable
|
 |
GTEX-15G19
|
61-70
|
Male
|
GTEX-15G19-1226 |
Liver
|
PAXgene |
2
|
2 pieces
|
Acceptable
|
 |
GTEX-15RJ7
|
41-50
|
Male
|
GTEX-15RJ7-2026 |
Liver
|
PAXgene |
1
|
2 pieces; mild steatosis
|
Acceptable
|
 |
GTEX-15RJE
|
41-50
|
Male
|
GTEX-15RJE-1126 |
Liver
|
PAXgene |
1
|
2 pieces; several focal hemorrhages [outlined]; capsule sampled
|
Acceptable
|
 |
GTEX-15SHU
|
41-50
|
Female
|
GTEX-15SHU-1826 |
Liver
|
PAXgene |
2
|
2 pieces; moderate central passive congestion
|
Acceptable
|
 |